CKD Bio (XKRX:063160) Marketable Securities : ₩70 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is CKD Bio Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. CKD Bio's Marketable Securities for the quarter that ended in Mar. 2024 was ₩70 Mil.

CKD Bio's annual Marketable Securities increased from Dec. 2021 (₩69 Mil) to Dec. 2022 (₩8,069 Mil) but then declined from Dec. 2022 (₩8,069 Mil) to Dec. 2023 (₩70 Mil).

CKD Bio Marketable Securities Historical Data

The historical data trend for CKD Bio's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio Marketable Securities Chart

CKD Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

71.58

69.99

69.03

8,069.21

69.55

CKD Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Marketable Securities	Get a 7-Day Free Trial															8,069.30	5,069.39	5,069.48	69.55	69.64

CKD Bio Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

CKD Bio (XKRX:063160) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

CKD Bio Marketable Securities Related Terms

Thank you for viewing the detailed overview of CKD Bio's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

CKD Bio (XKRX:063160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » Marketable Securities

Traded in Other Exchanges

N/A

Address

368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://www.ckdbio.com

CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio (XKRX:063160) Headlines

No Headlines